A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 226
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AC
Long Form : adjuvant chemotherapy
No. Year Title Co-occurring Abbreviation
2020 Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes. LARC, NAC, nCRT
2020 Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort. OS, RNU, UTUC
2020 Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis. DFS, GC, OS
2020 Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapy. IPTW, NCDB, OS, PMRT
2020 Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection. CRC, NAC, NACRT, OS, RFS
2020 Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. NAC, pCR
2020 Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis. CRT, DSS, LARC, OBS, OS, PS
2020 The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma. ALP, C-index, CCRT, NPC, OS, PI
2020 The impact of early adjuvant chemotherapy in rectal cancer. preCRT
10  2020 Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy? NAC
11  2019 Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. OS, PC
12  2019 Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer. OS, SA
13  2019 Adjuvant chemotherapy improves prognosis of resectable stage IV colorectal cancer: a comparative study using inverse probability of treatment weighting. CRC, HR, OS, RFS
14  2019 Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study. 5-FU, CRT
15  2019 Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis. ACR, HR, NCDB, OS
16  2019 Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. IPTW, LND, RC
17  2019 Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas. CI, CRNECs, HR, IPTW, OS
18  2019 Alterations in intestinal microbiota of colorectal cancer patients receiving radical surgery combined with adjuvant CapeOx therapy. CRC
19  2019 Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature. NAC, RPC
20  2019 Association among the prognostic nutritional index, completion of adjuvant chemotherapy, and cancer-specific survival after curative resection of stage II/III gastric cancer. CI, CSS, GC, HR, PNI
21  2019 Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis. CCRT, DMFS, HR, IC, LRFS, NPC, OS, PFS, TSA
22  2019 Clinical impact of additional therapy for residual pancreatic cancer. DFS, HR, MST, NAT, OS, PDAC, PSA
23  2019 Complications after discharge and delays in adjuvant chemotherapy following colonic resection: a cohort study of linked primary and secondary care data. CPRD, HES, HR, OS
24  2019 Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma. ---
25  2019 Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. CI, OS, PUC
26  2019 Does Neoadjuvant Chemotherapy Change the Role of Regional Lymphadenectomy in Pancreatic Cancer Survival? LN, NAC, OS, PDAC
27  2019 Effect of adjuvant therapy on the risk of recurrence in early-stage leiomyosarcoma: A meta-analysis. CI, OR, ULMS
28  2019 Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? OS, RC
29  2019 Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study. CSS, OS, RFS, RNU, UTUC
30  2019 Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study. CSS, HR, HV, RFS, UC
31  2019 Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers. NAC, OS, TTR
32  2019 Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect. MIBC, NAC, RC, RFS
33  2019 Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer. ASA, BMI, LN, OS
34  2019 Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study. AJCC, FJUUH, SEER
35  2019 Laparoscopic-assisted Versus Open D2 Gastrectomy for Advanced Gastric Cancer in Highly Selective Patients: Short-term Surgical and Chemotherapy Outcomes of a Prospective Cohort Study. AGC, LAD2G, OD2G
36  2019 Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management. CCRT, IC
37  2019 Lessons Learned Regarding Missing Clinical Stage in the National Cancer Database. NAC, NCDB
38  2019 Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. CI, MIBC, NAC, RC, RFS
39  2019 Neoadjuvant chemoradiation versus adjuvant chemotherapy for locally advanced adenocarcinoma of the rectosigmoid junction. AJCC, nCR
40  2019 Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study. LND, NAC, OS, PSCC, RF
41  2019 Phase 2 study of perioperative chemotherapy with SOX and surgery for stage III colorectal cancer (SOS3 study). CRC, NAC, SOX
42  2019 Preoperative inflammatory response as prognostic factor of patients with colon cancer. CC, mGPS, RFS
43  2019 Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer. aHR, BCa
44  2019 Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma. CI, HR, RAC
45  2019 Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. CRLM, HR, OS, PS, RFS
46  2019 The effect of Oncotype DX on adjuvant chemotherapy treatment decisions in early breast cancer. ODX, RS
47  2019 The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma. ECC
48  2019 Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. ACTCM, TCM
49  2019 Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. ENB, OS
50  2019 [Investigation of Colorectal Cancer Cases among Patients Aged over 75 Years Who Received Postoperative Adjuvant Chemotherapy]. ---
51  2018 A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. MRI, NAC, PFS, SCPRT
52  2018 Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. CR, CRT, DFFS, ESCC, LFFS, OS, PD, PR, SD
53  2018 Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes. IPLN, OS
54  2018 Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. IPTW, NAC, OS, RC, UCB
55  2018 Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection. nCRT, OB, OS
56  2018 Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients. GI
57  2018 Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. NACRT, OC, OS
58  2018 Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region. CC, CoC, GC, OS
59  2018 Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer. DRFS, ER, NAC, TN
60  2018 Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis. AR, RH
61  2018 Compliance with National Guidelines on the Treatment of Stage II–IVB Nasopharyngeal Carcinoma in a Regional Cancer Center of Southern China CCRT, IC
62  2018 Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City. ---
63  2018 Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis. CI, HR, RFS
64  2018 Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. CI, IPTW, OS, RC, UCB
65  2018 Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study. DMFS, HNMM, LRFS, OS, PNR, RRFS
66  2018 Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: ASingle-Center Retrospective Study. AEs, CI, DFS, EGFR, NSCLC
67  2018 Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. GI, MIS
68  2018 Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort. DCC, DFS, OS, PD, PS
69  2018 Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer. nCRT, RC
70  2018 Increased incidence of chemoport-related thrombosis in patients with colorectal cancer receiving bevacizumab: A single-institutional experience. BEV, CRC, CRT, PC
71  2018 Laparoscopic liver resection for colorectal liver metastasis patients allows patients to start adjuvant chemotherapy without delay: a propensity score analysis. CRLM, LLR, LR
72  2018 Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to Postoperative Adjuvant Chemotherapy. PDAC
73  2018 Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes. HER2, HR, NAC, TNBC
74  2018 Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database. CSS, DFS, MIBC, OS
75  2018 Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients. PD-L1, RC, RFS
76  2018 Real life adjuvant chemotherapy uptake and survival in patients with non-small cell lung cancer after complete resection. NSCLC
77  2018 Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study. CSS, RNU, UTUC
78  2018 Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients. dNLR, OS
79  2018 Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis. CI, DFS, OS, TNBC, WT
80  2018 The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis. CCRT, CI, HR, IC, NPC, RT
81  2018 Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer? CI, GC, HR, OS
82  2018 Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide. ---
83  2018 Who Can Perform Adjuvant Chemotherapy Treatment for Gastric Cancer? A Multicenter Retrospective Overview of the Current Status in Korea. DFS, PSM
84  2018 [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method]. NAC
85  2017 A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy. CTC, RC, UCB
86  2017 Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort. ART, HRs, LN, MVAC, OS, RC
87  2017 Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion. IQR, NSCLC
88  2017 Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis. AT, BTC, CT, HR, OS
89  2017 Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status. ---
90  2017 Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis. CSS, LVI, UTUC
91  2017 Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial. CCRT, NPC
92  2017 Adjuvant chemotherapy in resectable synovial sarcoma. OS, SS
93  2017 Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation. CRT, DFS, mrEMVI
94  2017 Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy. NAC, OS, RC
95  2017 Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological study. CC
96  2017 Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival. CI, HR, NAC, PC
97  2017 Chemotherapy use and survival in stage II nasopharyngeal carcinoma. CCRT, DMFS, LRFS, NPC, OS, RT
98  2017 Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature. OS, RPS, SA
99  2017 Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma. IPTW, OS, RNU, UTUC
100  2017 How equitable is access to treatment for lung cancer patients? A population-based review of treatment practices in Ontario. ---